Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump
June 11, 2014 at 11:24 AM EDT
Orexigen Therapeutics (NASDAQ: OREX) on Tuesday announced that the FDA has issued a three-month extension for the review of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.